Korea, Republic of (KR)

Prospects for PBR detection of KM3-230213A-like events (2025) Abdullahi M, Abrate M, Adams JH, Allard D, Alldredge P, Aloisio R, Ammendola R, et al. Conference contribution Five Years of Mini-EUSO Observations from the ISS: Summary of Key Results (2025) Abdullahi M, Abrate M, Adams JH, Allard D, Alldredge P, Aloisio R, Ammendola R, et al. Conference contribution Exploring a modified quantum dynamics based on Tsallis' distribution (2025) Chung WS, Junker G, Nieto LM, Hassanabadi H Journal article Correction to: Fine-mapping genomic loci refines bipolar disorder risk genes (Nature Neuroscience, (2025), 28, 7, (1393-1403), 10.1038/s41593-025-01998-z) (2025) Koromina M, Ravi A, Panagiotaropoulou G, Schilder BM, Humphrey J, Braun A, Bigdeli T, et al. Journal article, Erratum A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group (2025) Karschnia P, Young JS, Wijnenga MM, Sciortino T, Teske N, Corell A, Wagner A, et al. Journal article International norms for adult handgrip strength: A systematic review of data on 2.4 million adults aged 20 to 100+ years from 69 countries and regions (2025) Tomkinson GR, Lang JJ, Rubín L, McGrath R, Gower B, Boyle T, Klug MG, et al. Journal article, Review article A new late Neanderthal from Crimea reveals long-distance connections across Eurasia (2025) Pigott EM, Cheshmedzhieva K, Zeller E, van der Sluis LG, Chowdhury MP, Gianni M, Végh E, et al. Journal article, Original article Unveiling blazar synchrotron emission: A multiwavelength polarimetric study of high-synchrotron and low-synchrotron peaked populations (2025) Capecchiacci S, Liodakis I, Middei R, Kim DE, Di Gesu L, Agudo I, Agís-González B, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025) Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al. Journal article